Beta Drugs Limited — Board Meeting, 19-10-2024: Outcome of Board Meeting

Beta Drugs Limited's Board has approved changes including increasing the authorized share capital and issuing equity shares and compulsorily convertible debentures (CCDs) on a preferential basis. An extraordinary general meeting is scheduled for November 12, 2024, to seek shareholder approval for these matters. The proposed changes will enhance the company's capital structure and invite new investments from selected investors. Further details will be provided in the meeting agenda.